Riskpilot← Back to searchSign inGet full accessRESPINOR AS
ASActiveOrg 915417310Gaustadalléen 21, 0349 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20159 employees
Revenue 2024
NOK 2,8M
-7% vs 2023
EBITDA margin
-675.8%
-2% vs 2023
Equity ratio
72.2%
Financial strength
Net profit 2024
NOK -18,5M
-1% vs 2023
| Revenue | NOK 2,8M | -7% |
| EBITDA | NOK -18,6M | -2% |
| Net profit | NOK -18,5M | -1% |
| Total assets | NOK 11,2M | +168% |
| Equity | NOK 8,1M | +167% |
| Employees | 9 | — |
Legal name
RESPINOR AS
Org number
915417310
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
20. mai 2015
Share capital
NOK 6 126 921
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Daglig leder og styrets leder i fellesskap.
Company purpose
Utvikle, markedsføre og selge medisinske produkter og utstyr samt det som står i forbindelse med dette.
Address
Gaustadalléen 21, 0349 Oslo
Phone
+4724022554
Email
mail@respinor.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 417 | 4 305 | 7 833 | 15 999 | 12 858 | 2 842 | 10 532 | 9 633 | 2 946 | 2 751 |
| Staff expenses | −0 | −3 104 | −5 258 | −7 962 | −11 577 | −6 190 | −6 992 | −0 | −0 | −0 |
| EBITDA | −797 | −2 097 | −2 087 | −3 007 | −7 507 | −9 301 | −11 538 | −12 682 | −18 248 | −18 592 |
| Depreciation & amort. | −14 | −20 | −20 | −20 | −20 | −6 | −0 | −4 | −5 | −5 |
| EBIT | −811 | −2 117 | −2 107 | −3 027 | −7 527 | −9 307 | −11 538 | −12 685 | −18 253 | −18 597 |
| Net financials | 0 | −19 | 23 | −226 | −113 | −657 | −143 | −18 | −93 | 57 |
| Profit before tax | −811 | −2 137 | −2 084 | −3 253 | −7 641 | −9 963 | −11 681 | −12 703 | −18 346 | −18 539 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −811 | −2 137 | −2 084 | −3 253 | −7 641 | −9 963 | −11 681 | −12 703 | −18 346 | −18 539 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 362 | 8 711 | 24 009 | 9 847 | 6 412 | 9 756 | 19 376 | 7 891 | 4 174 | 11 174 |
| Equity | 160 | 6 690 | 9 332 | 6 165 | 3 600 | 3 640 | 14 984 | 6 280 | −12 066 | 8 064 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 4 654 | 0 | 0 | 13 725 | 0 |
| Short-term debt | 3 202 | 2 022 | 14 677 | 3 682 | 2 812 | 1 462 | 4 392 | 1 611 | 2 515 | 3 110 |
| Total debt | 3 202 | 2 022 | 14 677 | 3 682 | 2 812 | 6 116 | 4 392 | 1 611 | 16 240 | 3 110 |
EBITDA margin
-675.8%
This company
15.8%
Market median
-4377% vs market
20152024
Equity ratio
72.2%
This company
38.2%
Market median
+89% vs market
20152024
Return on equity
-229.9%
This company
18.4%
Market median
-1349% vs market
20152024
Net profit margin
-673.9%
This company
8.1%
Market median
-8420% vs market
20152024
Asset turnover
0.25×
This company
1.12×
Market median
-78% vs market
20152024
Debt / equity
0.39×
This company
0.62×
Market median
+37% vs market
20152024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TT Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Respinor Ab | Company | 93.9% | 93.9% | 2024 |
Respinor As | Company | 6.1% | 6.1% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RESPINOR AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Trude Tingvoll | Chief Executive Officer | 0 companies |
| Jan Fikkan | Deputy Chairman | 0 companies |
| Marco Graziano Renoldi | Board of Directors | 0 companies |
| Sten Gunnar Otto Skolling | Board of Directors | 0 companies |
| Aage Bryn | Board of Directors | 0 companies |
| Anders Wold | Chairman | 0 companies |
| Carl Christian Gilhuus-Moe | Board of Directors | 0 companies |